Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tengteng Xu

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Blood|February 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemiaAndreas Linder, Daniel Nixdorf, Niklas Kuhl, et al.
The Journal of Experimental Medicine|January 22, 2025
PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancersYing He, Wei Li, Meiling Zhang, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Blood|February 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemiaAndreas Linder, Daniel Nixdorf, Niklas Kuhl, et al.
The Journal of Experimental Medicine|January 22, 2025
PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancersYing He, Wei Li, Meiling Zhang, et al.
Pageof 4